Month: April 2019

Bedfont named International Business for the 2nd year in a row at the South East Federation of Small Businesses Awards

On Friday 12th April, Bedfont Scientific ltd was recognised as International Business of the Year for its 2nd year in a row at the South East Federation of Small Businesses (FSB) Awards 2019.

The FSB hosts annual Celebrating Small Business Awards to recognise the best small businesses across the UK. The UK is split into 12 regions and each region holds its own ceremony, with all regional winners going through to compete in the Nationals taking place on 23rd May at Evolution Battersea.

Despite being a small family business with only 43 employees, Bedfont’s medical devices can be found worldwide, with export sales accounting for 80% of turnover.

Jason Smith, Managing Director at Bedfont, says, “We are so proud and thrilled to have been named International Business of the Year 2019. There are a lot of great companies out there and we didn’t expect to be recognised for 2 years in a row. This award wouldn’t be possible without the hard work and dedication of the Bedfont family and its distributors, its thanks to them we can continue to innovate healthcare worldwide.”

This accolade is Bedfont’s 3rd regional exporting recognition and its 7th exporting award so far.

Bedfont® has announced the US Food and Drug Administration (FDA) clearance for its carbon monoxide (CO) breath analysis monitor which determines levels of CO poisoning

The ToxCO is a breath analysis monitor that measures exhaled carbon monoxide (CO) to give healthcare personnel an idea of CO levels in the blood, allowing them to triage cases of CO poisoning.

Unlike traditional methods, breath analysis with the ToxCO is non-invasive with instant results, saving time in critical situations. Breath samples can be taken via a low-cost mouthpiece allowing for point-of-care CO checking for mass casualties, aiding the decision of whether or not a patient needs to be treated at hospital. For patients who are unconscious or injured, a face mask option offers a modified sampling technique to indicate for CO poisoning. The monitor also automatically samples ambient air from switch-on, acting as an alarm when CO levels in the environment reach harmful levels.

Jason Smith, Managing Director at Bedfont comments, “Not only can our breath analysis monitor help to evaluate patients quickly and effectively for CO poisoning, but it can also reduce emergency department visits and hospitalizations. We are thrilled with the FDA approval of the ToxCO; we believe it will be game-changer for healthcare personnel in America.”

Bedfont already has an exclusive USA distributor for the ToxCO monitor, CoVita. Its President, Jason Aversano, expressed his excitement about the 510(K), stating “the ToxCO will be a useful tool for healthcare professionals such as paramedics in Firefighter Rehab. We believe it will fundamentally change how people are assessed for CO poisoning in the United States.”

Bedfont® Scientific Ltd. scoops Exporter of the Year for the 3rd time in a row at the Kent Invicta Chamber of Commerce awards.

On Thursday 21st March, the Kent Invicta Chamber of Commerce held their annual business awards and 2nd generation family business, Bedfont®, was named Exporter of the Year for the 3rd year in a row.

The awards, now in its 13th year, celebrates the excellent abundance of businesses in the county of Kent.

Bedfont®, based in Harrietsham, specialises in the design and manufacture of breath analysis medical devices.  Its range of carbon monoxide (CO) monitors include the Smokerlyzer®, used for smoking cessation, and the ToxCO®, used by emergency services, to screen for CO poisoning. The NObreath® FeNO monitor provides accurate analysis of airway inflammation to aid in the diagnosis and management of asthma, and the Gastrolyzer® range aids in the detection of gastrointestinal disorders and food intolerances.

Despite being a small family business with only 43 employees, Bedfont®’s medical analysers can be found worldwide, with export sales accounting for 80% of turnover, thanks to continuous innovation from the Bedfont® family and its network of carefully selected distributors, Bedfont®’s extended family.

Jason Smith, Managing Director at Bedfont®, comments, “Exporting for any company is no easy feat. For Bedfont®, our greatest challenge can be our size, but with dedicated employees and distributors we have managed to achieve this. We are utterly humbled to have won this award for the 3rd year in a row – it really acknowledges the efforts of the Bedfont® family, our employees and distributors, and I am honoured to share this prestigious award with them.”